Sugi Predict

Sugi Predict / Compounds / SCHEMBL10399191

SCHEMBL10399191

SCHEMBL10399191

Nc1cc(Cl)c2nc[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.34
▸ BRAF P15056 3/20 0.33
▸ POLA1 P09884 1/20 0.33
▸ PNP P00491 1/20 0.33
▸ IP6K1 Q92551 1/20 0.33
▸ DAPK3 O43293 2/20 0.33
▸ PRKD3 O94806 2/20 0.33
▸ MAP4K4 O95819 2/20 0.33
▸ PAK4 O96013 2/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ PRKACA P17612 2/20 0.33
▸ CSNK1A1 P48729 2/20 0.33
▸ CLK2 P49760 2/20 0.33
▸ GSK3B P49841 2/20 0.33
▸ CDK7 P50613 2/20 0.33
▸ CDK9 P50750 2/20 0.33
▸ PRKX P51817 2/20 0.33
▸ JAK3 P52333 2/20 0.33
▸ CDK5 Q00535 2/20 0.33
▸ MAP4K2 Q12851 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2316808 0.80 CSNK2A1 (0.34) DPP4IP6K1DAPK3PRKD3MAP4K4
SCHEMBL29574753 0.80 CSNK2A1 (0.34) DPP4IP6K1DAPK3PRKD3MAP4K4
SCHEMBL22757469 0.77 PIM1 (0.36) DPP4POLA1PNPIP6K1DAPK3
SCHEMBL16774129 0.77 CSNK2A1 (0.40) IP6K1DAPK3PRKD3MAP4K4PAK4
6-Chloroguanine SCHEMBL29475378 0.71 DPP4 (0.52) DPP4BRAFPNPDAPK3PRKD3
SCHEMBL30115173 0.71 CDK1 (0.41) DPP4POLA1PNPCSNK1A1CLK4
SCHEMBL29745 0.71 CDK1 (0.41) DPP4POLA1PNPCSNK1A1CLK4
6-Chloroguanine SCHEMBL6711 0.71 DPP4 (0.52) DPP4BRAFPNPDAPK3PRKD3
SCHEMBL1358951 0.69 CDK1 (0.40) DPP4POLA1PNPCSNK1A1CLK4
6-Chloroguanine SCHEMBL8715987 0.69 DPP4 (0.50) DPP4BRAFPNPDAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074398-B1 A3 ADENOSINE RECEPTOR AGONISTS US HEALTH (US) 2021-03-17 — — EP disclosed
US-10577368-B2 A3 adenosine receptor agonists THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-03-03 — — US disclosed
US-9963450-B2 A3 adenosine receptor agonists THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-05-08 — — US disclosed
US-9963450-B2 A3 adenosine receptor agonists THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-05-08 — — US disclosed
US-20170002007-A1 A3 ADENOSINE RECEPTOR AGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2017-01-05 — — US disclosed
US-20170002007-A1 A3 ADENOSINE RECEPTOR AGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2017-01-05 — — US disclosed
WO-2015080940-A1 A3 ADENOSINE RECEPTOR AGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2015-06-04 — — WO disclosed
EP-1474425-B9 DEAZAPURINES AND USES THEREOF EISAI CO LTD (JP) 2008-07-02 — — EP disclosed
US-4977144-A ADENOSINE AGONISTS CIBA-GEIGY CORPORATION (US) 1990-12-11 — — US disclosed
EP-0354180-A2 Certain imidazo[4,5-b]pyridine derivatives CIBA-GEIGY AG (CH) 1990-02-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10577368-B2 A3 adenosine receptor agonists ADORA3, ADORA2B, ADORA1 DPP4 2357/4885BRAF 1821/4885POLA1 2243/4885
US-20170002007-A1 A3 ADENOSINE RECEPTOR AGONISTS ADORA3, ADORA2B, ADORA1 DPP4 2472/4885BRAF 1803/4885POLA1 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.